IBA BUSINESS UPDATE – FIRST QUARTER 2019

    NEXT STORY
    Roche to present new OCREVUS (ocrelizumab) data analyses showing significant reduction of disability progression in relapsing and primary progressive multiple sclerosis at the AAN Annual Meeting
    PREV STORY
    OPKO Health Reports 2019 First Quarter Business Highlights and Financial Results
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Dova Pharmaceuticals Reports Third Quarter 2018 Operating and Financial Results

    Third quarter net product sales of $2.9 million from DOPTELET® (avatrombopag); 335 cumulative unique ...

    author_avatar
    NASDAQ Market News

    AgEagle Receives Follow-On Purchase Orders to Manufacture Commercial Drones for Package Delivery

    author_avatar
    NASDAQ Market News

    Kannalife, Inc. Announces Completion of NIH-NIDA Phase 1 Grant and Results from Lewis Katz School of Medicine at Temple University for the Potential Use of KLS-13019 in the Treatment of CIPN

    author_avatar
    NASDAQ Market News